Trending Hot: iPad 3 | Google Drive | Windows Guide | Jailbreak
Premium WP Theme | Amazon Shop | Unlocking Support | MacKeeper

Big Step Ahead in Quest for HIV Vaccine

Reporter: Under: Science On July 9, 2010 2 Comments
Add to Bookmark Add to Readlist

HIV research is undergoing a renaissance that could lead to new direction to develop vaccines against the AIDS virus and other viral diseases.

In the latest development, U.S. government scientists say they have discovered three powerful antibodies, the strongest of which neutralizes 91% of HIV strains, more than any AIDS antibody yet discovered. They are now deploying the technique used to find those antibodies to identify antibodies to influenza viruses.

The antibodies could be tried as a treatment for people already infected with HIV, the WSJ reports. At the very least, they might boost the efficacy of current antiretroviral drugs.

[VACCINE]

A vaccine for HIV, the virus that causes AIDS, would likely work by activating the body’s own ability to produce antibodies that would ward off the disease. The latest discovery is more promising than a trial in Thailand last year in which scientists said an HIV vaccine reduced the chances of infection by just 30 percent. That study had also been plagued with controversy because in one analysis, the results were not statistically significant.

The WSJ says the new discovery — involving scientists from the National Institutes of Health, Harvard Medical School, Howard Hughes Medical Institute and Columbia University — is part of a renaissance in HIV vaccine research, which will be in focus later this month in Vienna, home to this year’s International AIDS Conference.

It is welcome news for the the 33 million people the United Nations estimated were living with AIDS at the end of 2008.

The WSJ outlines the painstaking method the team used to find the antibody amid the cells of the African-American man, known as Donor 45. First they designed a probe that looks just like a spot on a particular molecule on the cells that HIV infects. Then they used the probe to attract only the antibodies that efficiently attack that spot. They screened 25 million of Donor 45′s cells to find just 12 cells that produced the antibodies.

Scientists have already discovered plenty of antibodies that either don’t work at all or only work on a couple HIV strains. Last year marked the first time that researchers found “broadly neutralizing antibodies,” which knock out many HIV strains. But none of those antibodies neutralized more than about 40 percent of them, the WSJ says. The newest antibody, at 91 percent neutralization, is a marked improvement.

Still, more work needs to be done to ensure the antibodies would activate the immune system to produce natural defenses against AIDS, the study authors say. They suggest three test methods that blend the three new antibodies together — in raw form to prevent transmission of the virus, such as from mother to child; in a microbicide gel that women or gay men could use before sex to prevent infection; or as a treatment for HIV/AIDS, combined with antiretroviral drugs.

If the scientists can find the right way to stimulate production of the antibodies, they think most people could produce them, the WSJ says.

Finally, there are experimental methods that employ tactics such as gene therapy. Nobel laureate David Baltimore is working on one such approach.

His team at the California Institute of Technology in Pasadena, Calif., has stitched genes that code for antibodies into a harmless virus, which they then inject into mice. The virus infects mouse cells, turning them into factories that produce the antibodies.

Source: Wall Street Journal

Recent Tech News

Facebook has become increasingly important for the brands to stay relevant and important on the social media. Facebook pages are a central hub for most brands to connect with their millions of fans and the social network keeps adding newer features to make this more easy and convenient. Now, Facebook has added yet another feature to pages.

Smile is a great way to express pleasure or joy at something or someone. But more often than not, it has to be forced and is fake. While that may work for a lot of people perfectly well, things are about to change. A new technology from MIT can now detect if your smile is true or fake, thus busting you right on spot for pulling that false grin.

Google has working hard to improve its Google Play platform, so as to pitch it effectively enough against Apple’s popular App Store. While Google Play still has a lot of catching up to do, the good thing is that Google is regularly adding newer and better features to its platform. Now, for instance, Google has added the option of in-app subscriptions for Google Play.

KDE has launched a Partner Network for its Vivaldi tablet, the first ever KDE powered tablet. The Vivaldi tablet is a 7-inch tablet which will run on Mer Linux or KDE Plasma Active with an ARM-based processor. This tablet will be shipped from the next month for around €200 (~$314.74). The company did not announce the US price yet. Unfortunately, the company does not accept the pre-orders at this time.

Tags: , , , , , , ,

  On July 9, 2010(1 year, 10 months ago.)
  • sumadija

    you can read many things that they have found out but what then? When will be a cure possible???
    why do not the researchers together, pooling their resources together so they can achieve more results????

  • mauhc

    you all dont have anything to say then to say searching for a cure why the cure is in ur hand but how which i way a doctor ??????


Recent Search
Tags
3D 3G Amazon Android App Apple Application Apps App Store AT&T Bluetooth. breaking news camera download entertainment Facebook features free free app Game Gaming Google HD HDMI How To HTC intel iOS iPad iPad 2 iPhone iPhone 3GS iPhone 4 iPhone app iPod ipod touch itunes iTunes link jailbreak Laptop MAC Microsoft Mobile news PC review samsung smartphone Software Sony Tablet tablets Tutorial Twitter update Verizon version video Wi-Fi Windows Windows 7
Close You Have To Login
User:
Pass:
Login With »Login With TwitterLogin With Facebook